meta_pixel
Tapesearch Logo
Log in
Behind The Knife: The Surgery Podcast

Clinical Challenges in Breast Surgery: Triple Negative Breast Cancer

Behind The Knife: The Surgery Podcast

Behind The Knife: The Surgery Podcast

Science, Health & Fitness, Medicine, Education

4.81.4K Ratings

🗓️ 2 August 2021

⏱️ 28 minutes

🧾️ Download transcript

Summary

A young woman is referred urgently to your breast surgical oncology clinic for a second opinion. She has been told that she needs to have an urgent mastectomy for a palpable triple negative breast cancer with suspicious axillary lymphadenopathy. Are there other options she should consider? Join Drs. Michael Alvarado, Rita Mukhtar, and Alexa Glencer as they discuss the multidisciplinary management of a patient with triple negative breast cancer.


In this episode, we review the diagnosis and classification of triple negative breast cancer, its biologic implications, surgical management including the role of sentinel lymph node biopsy vs axillary dissection, and the role of targeted chemotherapy including the recent FDA approval of immunotherapy for triple negative breast cancer in the neoadjuvant setting and indication for adjuvant chemotherapy for patients with residual disease following neoadjuvant therapy.


Links:
Enhanced recurrence and survival benefit of adjuvant chemotherapy for hormone receptor negative breast cancer compared to hormone receptor positive breast cancer
Berry et al (2006). Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA; 295(14): 1658-1667.


Neoadjuvant pembrolizumab for triple negative breast cancer
Schmid et al (2020). Pembrolizumab for early triple negative breast cancer. New England J of Medicine; 382(9): 810-821.


ACOSOG 1071: Sentinel lymph node biopsy for patients who received neoadjuvant chemotherapy
Boughey at al (2013). Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG 1071 (Alliance) clinical trial. JAMA; 310(14): 1455-1461.


Adjuvant capecitabine for triple negative breast cancer patients with residual disease following neoadjuvant chemotherapy:
Masuda et al (2017). Adjuvant capecitabine for breast cancer after preoperative chemotherapy. New England J of Medicine; 376(22): 2147-2159.

Transcript

Click on a timestamp to play from that location

0:00.0

Debt has a family, no kids is married and divorced.

0:03.5

It's a school run grand, a key worker, a father in the force.

0:06.9

Debt's a fumbuff, a football fan, a good cook and a gardener.

0:10.1

It's a flat chair, got a mortgage, lives alone and with a partner.

0:13.6

Debt's 23, 41 and even 92.

0:16.5

It's stressed out, can't sleep and wondering what to do.

0:19.9

Debt can happen to anyone.

0:21.7

We've helped millions leave it behind.

0:24.0

Visit stepchange.org to get help now.

0:26.7

Stepchange is authorized and regulated by the Financial Conduct Authority.

0:30.0

Behind the knife, the surgery podcast,

0:33.2

where we take a behind-the-scenes intimate look at surgery from leaders in the field.

0:37.6

This is a heavy milk bar at the end of my bed.

0:58.5

I'm Heidi from ID.

1:00.0

Stop hibernating.

1:01.4

You could get a bare phone deal.

1:03.7

ID mobile can save you an average of 215 pound a year versus the major networks.

1:08.5

I must be dreaming.

1:10.8

99% coverage of the population does feel like a dream, but it's very real Alan.

1:15.4

ID mobile.

1:17.8

Visit idmobile.co.uk forward slash save for verification.

1:21.4

Debt has a family, no kids is married and divorced.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Behind The Knife: The Surgery Podcast, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Behind The Knife: The Surgery Podcast and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.